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Table 1. The lag time tlag and the phase transformation rate constant K 
METHODOLOGY 
The anhydrate to hydrate phase transformation of CBZ and PRX were 
measured by dispersing CBZA and PRXA in ethanol-water mixture and 
water respectively, while controlling temperature and stirring rate. Raman 
spectra of the slurries were recorded at fixed time intervals. The amount 
of converted material were calculated using orthogonal partial least 
squares (OPLS) calibration models.   
The conversion data were then fitted to equation 1, using a four 
parameter non-linear least squares routine (in-house programmed 
Matlab® routine). The conversion rate constant and the lag time (tlag)  
were extracted using equation 2 and as the intercept between the 
baseline and the tangent to t50% conversion  respectively (Table 1).  
Figure 2. Solubility of as a 
function of temperature. A) 
Solubility of CBZ anhydrate and 
CBZ dihydrate in ethanol:water 
mixture (39 mol% of water),  B) 
Solubility of PRX anhydrate and 
PRX monohydrate in water.  
Figure 4. Conversion data for CBZ and PRX at different temperatures, the blacks 
line are the curves fitted to eq. 1. A) CBZA to CBZH conversion in 39 mol% water, B) 
PRXA to PRXH conversion in water.    
Carbamazepine Piroxicam 
Temperature (oC) tlag (min) K (min
-1) Temperature (oC) tlag (min) K (min
-1) 
8 21 0.485 40 54 0.06043 
10 30 0.183 50 41 0.08129 
12 54 0.137 60 25 0.12093 
14.5 142 0.088 70 37 0.14400 
80 38 0.16722 
Figure 1.  Chemical structure of  
A) carbamazepine, B) piroxicam  
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Figure 3. Transition 
temperature between CBZA 
and CBZH in different 
ethanol:water mixtures.  
RESULTS 
 
 
 
 
 
 
 
 
•The solubility profiles for CBZ and PRX are very 
different (fig. 2a+2b). For CBZ there is a crossover of 
the two curves defining a transition temperature, 
whereas there are no crossover and no defined 
transition temperature for PRX. PRXA has a higher 
solubility than PRXH at all measured temperatures. The 
majority of small organic compounds capable of forming 
hydrate behaves similar to carbamazepine.  
•The transition temperature for CBZ is a function of the 
ethanol:water ratio (fig.3).  
•The transformation rate constant K characterizes the crystal 
growth kinetics of the hydrate, whereas the lag time tlag 
characterizes the nucleation rate of the hydrate.  
 
•Carbamazepine: With increasing temperature up to the 
transition temperature, K decreases and tlag increases as a 
function of temperature (fig. 4a, table 1)., which fits well with 
the decreased solubility ratio of CBZA to CBZH (fig. 5) 
 
*Abbrevation used: carbamazepine anhydrate III (CBZA), carbamazepine dihydrate (CBZH), piroxicam anhydrate I (PRXA), piroxicam monohydrate (PRXH) 
OBJECTIVES 
The purpose of this study is to reveal the underlying mechanism of the 
acceleration and deceleration effects of temperature on solvent-mediated 
anhydrate to hydrate transformation. 
 
 
INTRODUCTION 
Both acceleration and deceleration effects of temperature on the solvent-
mediated anhydrate to hydrate phase transformation have been reported 
in the literature. However, there is very limited understanding of the 
underlying principle behind these effects. The transformation behaviors of 
carbamazepine* (CBZ) and piroxicam* (PRX) are significant different and 
they were therefore chosen for this study (fig. 1). 
 
•The solid state transformation is affected by thermodynamic as well as kinetic factors, 
which both are affected by temperature.  
 Thermodynamic factors: E.g. the solubility differences between solid state forms. 
 Kinetic factors:  E.g. dissolution kinetics, nucleation and growth kinetics. 
 
Figure 5. Solubility ratio of 
CBZA to CBZH, and PRXA 
to PRXH 
 
•Piroxicam: The transition rate constant K increases as a function of temperature. For 
the tlag there is a minimum around 60°C indicating that the contribution of the kinetic 
factors are different and more complex than in the case of CBZ (fig. 4b, table 1). The 
solubility ratio of PRXA to PRXH also shows a complex function of temperature with a 
turning point around 50°C (fig. 5). 
CONCLUSIONS 
Solvent mediated phase transformation is a complex process, and temperature is 
mainly affecting the transformation kinetic in two different ways. For some API such as 
CBZ, increase in temperature decreases the supersaturation of the stable form, thus 
slowling down the nucleation and crystal growth. However for other API such as PX, 
increase in temperature is proportional to increase in nucleation and growth kinetics of 
crystals.  
